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The Efficacy of Electrocardiograms as a Screening Tool to Detect 
Cardiac Abnormalities in Young Athletes 
Abstract 
Introduction 
• Sudden Cardiac Death: 
– death occurring in a patient with previously stable cardiac 
function until time of collapse. 
– cardiac demise taking place within one hour of symptom 
onset.  
• Athletes presumed to be healthy and in good condition are 
often affected by SCD due to cardiac abnormalities 
undetected by history and physical exam.  
• Cardiovascular screening is a diagnostic tool to improve a 
clinician’s plan of care and decrease SCD in athletes.  
Research Questions 
Literature Review 
Applicability to Clinical 
Practice 
Acknowledgments 
• Drezner et al. (2011) report the incidence of sudden cardiac 
death in the United States in high school athletes aged 14-17 
years old is 1/23,000. 
• Maron et al. (2007) reported incidence of SCD to be 
1/166,000 in competitive athletes aged 12-35 years.  
• The low incidence of SCD in the United States drives 
screening recommendations and supports debates over cost 




















Sheikh et al. (2014) 
 
• Wisten et al. (2004) reported increased sensitivity for the 
ECG to detect cardiovascular abnormalities over the H&P. In 
66 cases of SCD, only 18% had a positive family history, 
while 82% revealed previous ECG abnormalities. 
• Corrado et al. (2006) reported a 10-fold reduction in SCD in 
Italy among competitive athletes with an 89% reduction in 
deaths as a result of cardiomyopathy when the ECG was 
added to the H&P.  A 7% false-positive rate and a 2% 
disqualification rate. 
• Maron et al. (1987) reported a false-positive rate of 15% for 
the ECG. 
• Riding et al. (2014) maintains that black athletes still have 
higher percentages of abnormal ECGs than their Arabic and 
Caucasian counterparts.  
• Roberts et al. (2013) argues that the high false-positive values 
will result in unnecessary secondary testing that will increase 
the cost of ECG screening in large populations of athletes. 
• Wheeler et al. (2010) maintained that compared with H&P the 
addition of the ECG saves 2.1 life years for every 1,000 
athletes screened at a cost of $88 per athlete.  
 
• Sudden cardiac death (SCD) among athletes can be attributed 
to increased cardiovascular demands associated with vigorous 
exercise. 
• The majority of athletes who experience sudden cardiac death 
are asymptomatic. 
• Pre-participation history and physicals, (H&P) help to 
identify underlying cardiovascular disorders with the 
potential to increase the risk of SCD in an athlete.  
• The efficacy of pre-participation H&Ps to identify underlying 
cardiac etiology has been debated. 
• The purpose of this research is to: 
– Determine incidence and cause of SCD among athletes 
(Table 1). 
– Determine the efficacy and evidenced-based criteria for the 
interpretation of ECGs in athletes. 
– Evaluate cost-effectiveness of screening with ECG. 
• The findings indicate: 
– Incidence of SCD is 1-3/100,000 athletes. 
– The addition of ECG to the H&P improves sensitivity to 
70% and specificity to 94.1% resulting in early detection of 
cardiac abnormalities and decreases the incidence of SCD. 
– The refined criteria significantly reduces false-positive rates 
for ECG interpretation (p<0.0001). 
– The ECG saves an additional 2.1 life years/1000 athletes 




• In athletes <35 years of age, will the addition of an ECG to 
the H&P exam, compared to an isolated H&P, improve the 
detection of occult cardiac conditions, decreasing the 
incidence of sudden cardiac death? 
• With the addition of the ECG to the pre-participation H&P, 
what criteria will reduce the number of false-positives, 
improving the specificity of the ECG for detecting cardiac 
abnormalities? 
• Is the ECG a cost-effective component, compared to the sole 
H&P exam that is currently required for athlete participation 
in competitive sports? 
 
Table 1. Causes of Sudden Cardiac Death Among Athletes in the United States 
• Athletes not accustomed to exercise are at greater risk for 
SCD due to increased sympathetic tone resulting in 
arrhythmias.  
• Asif et al. (2013) Hypertrophic cardiomyopathy (HCM) and 
coronary artery anomalies are the leading identifiable cardiac 
causes of SCD in athletes from the United States (Table 1). 
• Rodday et al. (2012) reported a prevalence of HCM detected 
by ECG of 45/100,000, 84.7% sensitivity, 84.8% specificity 
with a number needed to screen to detect one case of 2,624 
and 399 false positives (p <0.001). 
• Maron et al. (1996) reported 158 sudden deaths among 
athletes with 134 having direct cardiovascular causes.  115 of 
the 134 had participated in a standard pre-participation H&P, 
and only four (3%) were detected as having cardiac disease.  
• Sheikh et al. (2014) the refined criteria (Table 2) reduces the 
number of ECGs categorized as abnormal from 21.5% to 
6.6%, with a significant reduction in the number of abnormal 
ECGs in both black and white athletes, to 11.5% and 5.3% 
respectively (p<0.0001). 
• Borjeson et al. (2011) reported adding the ECG to the H&P 
saves 2.06 life-years per 1000 athletes screened, costing USD 
42,000 per life-year saved, compared to screening without an 
ECG.  
• Lampert et al. (2013) reported cost of the H&P exam ranged 
from $224 to $313/athlete/year, and ECGs ranged from $39 to 
$47/athlete/year, only 15-18% of the combined price.  
• Utilization of an ECG does not replace the H&P exam. 
• The refined criteria is paramount to interpret ECGs in athletes 
and reduce false-positives.  
• AHA recommends against routine use of an ECG for 
screening in athletes. (Drezner et al., 2011). 
• Rodday et al. (2012) a screening program needs “high pre-
clinical prevalence in the screened population, a highly 
discriminatory test, the disease is serious, and asymptomatic 
treatment decreases morbidity and mortality.”  
• Drezner et al. (2011) Prevalence of cardiovascular conditions 
with the potential for SCD should dictate screening 
procedures, rather than the incidence of SCD.   
• Dr. Vikki McCleary, Dr. Sue Kuntz and all faculty in the Department of 
Physician Assistant Studies. 
Statement of the Problem 
• The pre- participation sports examination traditionally 
consists of a H&P. 
• The efficacy of the pre-participation H&P to identify 
underlying cardiac etiology has been debated as 
signs/symptoms of SCD may go undetected in the 
asymptomatic athlete. 
• The athlete’s heart produces normal physiological ECG 
changes that mimic pathologic conditions making 
interpretation difficult.  
Discussion 
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